PharmaTimes MSEA and NIEA awards are open for entry
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024
Read More
Author: Jen Brogan
BBSRC invests £48m in Babraham Institute to advance lifelong health research
The funding will help to support research across epigenetics, immunology and cell signalling
Read More
NHS reduces long waits for cancer care and achieves faster ambulance responses
For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer
Read More
MHRA’s AI Airlock to address challenges for regulating AI medical devices
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
Read More
Oregon and Lantern collaborate to develop drug candidate for various cancer indications
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
